## SCHW: The Charles Schwab Corporation - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 0.70 indicates fundamental undervaluation. Quality metrics strong (ROE 17%). Consistent execution (4/4 quarters beat estimates). Caution: declining volume (39% of avg), overbought RSI (73).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($98.25)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Greenup Street Wealth Management LLC Sells 12,470 Shares of The Charles Schwab Corporation $SCHW**
- Source: MarketBeat | 20251227T115014 | Neutral | Relevance: 100%
- Greenup Street Wealth Management LLC reduced its stake in The Charles Schwab Corporation by 26.4%, selling 12,470 shares and now holding 34,707 shares valued at approximately $3.31 million. Insider transactions included Paul V. Woolway selling 3,205 shares and Jonathan S. Beatty selling 3,072 shares, decreasing their holdings. Analysts maintain a "Moderate Buy" rating with an average price target of $108.84 for SCHW.

**2. Burney Co. Boosts Holdings in The Charles Schwab Corporation $SCHW**
- Source: MarketBeat | 20251227T093527 | Bullish | Relevance: 100%
- Burney Co. increased its stake in The Charles Schwab Corporation by 26.9% in Q3, now owning 226,656 shares valued at approximately $21.64 million. Charles Schwab reported strong Q3 earnings, beating analyst expectations with EPS of $1.31 and revenue of $6.38 billion. The company maintains a "Moderate Buy" consensus rating from analysts with an average target price of $108.84 and pays an annualized dividend of $1.08.

**3. Charles Schwab (SCHW): Reassessing Valuation After Technical Breakout and Strategic Platform Overhaul**
- Source: Simply Wall Street | 20251225T214547 | Bullish | Relevance: 100%
- Charles Schwab (SCHW) has recently broken above $100 for the first time in over a year, coinciding with an overhaul of its trading platforms. Despite the strong one-month performance (+12%) and five-year total shareholder return (>100%), the article explores whether the stock is still undervalued given its robust earnings growth and analyst targets. While a narrative valuation suggests a 10% undervaluation based on long-term earnings power and digital transformation, a P/E ratio exceeding a "fair ratio" suggests potential valuation risk if sentiment shifts.

**4. DAVENPORT & Co LLC Sells 78,030 Shares of The Charles Schwab Corporation $SCHW**
- Source: MarketBeat | 20251225T091005 | Somewhat-Bullish | Relevance: 100%
- DAVENPORT & Co LLC reduced its stake in The Charles Schwab Corporation by 26.9% in Q3, selling 78,030 shares, now holding 212,211 shares valued at $20.31 million. Charles Schwab exceeded Q3 expectations with an EPS of $1.31 and revenue of $6.38 billion, leading analysts to a "Moderate Buy" rating and an average price target of $108.84. Insider selling has also been noted, while institutional investors hold a significant 84.38% of the company's stock.

**5. Charles Schwab to Match Federal Contributions to Employees’ Children’s Trump Accounts**
- Source: planadviser | 20251224T172733 | Bullish | Relevance: 100%
- Charles Schwab announced it will match the federal government's $1,000 contribution to Trump Accounts for its U.S. employees' children, aiming to help families build long-term financial security. The federal pilot program provides a one-time $1,000 payment from the U.S. Treasury to tax-advantaged savings accounts for children born between 2025 and 2028. Many details regarding the accounts, such as specific tax advantages and administering providers, are still unconfirmed.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-22 | Morgan Stanley | $148 | $139 | +6% |
| 2025-12-12 | Barclays | $111 | $115 | -3% |
| 2025-12-10 | B of A Securiti | $91 | $88 | +3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-22 | Morgan Stanley | main | Overweight |
| 2025-12-12 | Barclays | main | Overweight |
| 2025-12-10 | B of A Securiti | main | Underperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 5 ($0.06M) |
| Sells | 16 ($14.65M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 8.5% (+0.3%)
- Blackrock Inc.: 7.4% (+3.2%)
- JPMORGAN CHASE & CO: 6.8% (+71.6%)
- Dodge & Cox Inc.: 4.7% (-1.6%)
- State Street Corpora: 4.1% (+0.9%)

### Key Risks

1. Volume divergence: price rising (+0.2% MRS) on declining volume (39% of avg) suggests distribution.
2. Heavy insider selling: $15M sold (16 transactions in 90 days).
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.70 indicates undervaluation relative to growth. Quality metrics strong (margin 36%). Insider selling cluster ($14.6M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $185.0B |
| Beta | 0.96 |
| 52W Range | $65.88 - $102.28 |
| Short Interest | 1.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.70 |
| Forward P/E | 18.1 |
| Current P/E | 21.2 |
| YoY Growth | 17.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 stable at 4.7% (minimal 5-day change). Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 92nd percentile. MRS_5 at 0.5% confirms short-term momentum alignment. AM_20 at 5.7% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.73), confirming momentum. RSI overbought at 73, risk of mean reversion. Volume at 39% of 20MA suggests lack of conviction. OFD pattern: -SBL (Volatile).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 4.69% (CS: 93) | Strong |
| RSI_14 | 73.1 | Overbought |
| MACD Histogram | 0.73 | Bullish |
| vs SMA20 | 1.057x | Above |
| vs SMA50 | 1.074x | Above |
| vs SMA200 | 1.129x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $101.89
- **Stop Loss:** $98.25 (3.6% risk)
- **Target:** $109.17 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 362
- **Position Value:** $36,884.18
- **Portfolio %:** 36.88%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with selective risk appetite amid holiday trading. VIX at extreme lows (13.6) signals complacency while positive yield curve (+59bps) and stable economic data support continuation. Focus on quality names with AI/infrastructure exposure while monitoring January volatility reset.*

### Earnings

**Next:** 2026-01-21 (Est: $1.33)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.25 | $1.31 | +5.2% |
| 2025Q2 | $1.10 | $1.14 | +3.8% |
| 2025Q1 | $1.01 | $1.04 | +3.2% |
| 2024Q4 | $0.91 | $1.01 | +10.5% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*